RAFFA WEALTH MANAGEMENT, LLC’s Gilead Sciences GILD Stock Holding History

RAFFA WEALTH MANAGEMENT, LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.5K	Sell	186 -9	-5%	-$1.19K	﹤0.01%	260
2026 Q1	$27.2K	Buy	195 +33	+20%	+$4.62K	﹤0.01%	227
2025 Q4	$19.9K	Buy	162 +35	+28%	+$4.25K	﹤0.01%	262
2025 Q3	$14.1K	Buy	127 +22	+21%	+$2.5K	﹤0.01%	306
2025 Q2	$11.6K	Hold	105	–	–	﹤0.01%	347
2025 Q1	$11.8K	Sell	105 -114	-52%	-$11.8K	﹤0.01%	287
2024 Q4	$20.2K	Buy	219 +114	+109%	+$10.3K	﹤0.01%	231
2024 Q3	$8.8K	Hold	105	–	–	﹤0.01%	328
2024 Q2	$7.2K	Hold	105	–	–	﹤0.01%	496
2024 Q1	$7.69K	Sell	105 -13	-11%	-$1K	﹤0.01%	457
2023 Q4	$9.56K	Hold	118	–	–	﹤0.01%	304
2023 Q3	$8.84K	Hold	118	–	–	﹤0.01%	295
2023 Q2	$9.09K	Hold	118	–	–	﹤0.01%	298
2023 Q1	$9.79K	Hold	118	–	–	﹤0.01%	302
2022 Q4	$10.1K	Hold	118	–	–	﹤0.01%	281
2022 Q3	$7.28K	Hold	118	–	–	﹤0.01%	319
2022 Q2	$7.29K	Hold	118	–	–	﹤0.01%	321
2022 Q1	$7.01K	Sell	118 -14	-11%	-$895	﹤0.01%	343
2021 Q4	$9.59K	Buy	132 +14	+12%	+$964	﹤0.01%	311
2021 Q3	$8.24K	Sell	118 -2	-2%	-$141	﹤0.01%	285
2021 Q2	$8.26K	Sell	120 -7	-6%	-$467	﹤0.01%	283
2021 Q1	$8.21K	Sell	127 -49	-28%	-$3.16K	﹤0.01%	306
2020 Q4	$10.3K	Buy	176 +12	+7%	+$724	﹤0.01%	245
2020 Q3	$10.4K	Buy	164 +30	+22%	+$2.08K	﹤0.01%	237
2020 Q2	$10.3K	Buy	134 +3	+2%	+$230	﹤0.01%	224
2020 Q1	$9.79K	Buy	131 +4	+3%	+$276	﹤0.01%	208
2019 Q4	$8.25K	Hold	127	–	–	﹤0.01%	237
2019 Q3	$8.05K	Buy	+127	New	+$8.3K	﹤0.01%	236
2019 Q2	–	Sell	-127	Closed	-$8.26K	–	984
2019 Q1	$8.26K	Hold	127	–	–	﹤0.01%	196
2018 Q4	$7.94K	Hold	127	–	–	﹤0.01%	220
2018 Q3	$9.81K	Hold	127	–	–	﹤0.01%	221
2018 Q2	$9K	Hold	127	–	–	﹤0.01%	213
2018 Q1	$9.57K	Buy	127 +97	+323%	+$7.71K	﹤0.01%	208
2017 Q4	$2.15K	Hold	30	–	–	﹤0.01%	239
2017 Q3	$2.43K	Hold	30	–	–	﹤0.01%	254
2017 Q2	$2.12K	Hold	30	–	–	﹤0.01%	284
2017 Q1	$2.04K	Sell	30 -34	-53%	-$2.39K	﹤0.01%	263
2016 Q4	$4.58K	Hold	64	–	–	﹤0.01%	225
2016 Q3	$5.06K	Sell	64 -6,400	-99%	-$520K	﹤0.01%	221
2016 Q2	$539K	Hold	6,464	–	–	0.3%	19
2016 Q1	$594K	Hold	6,464	–	–	0.34%	17
2015 Q4	$654K	Hold	6,464	–	–	0.39%	15
2015 Q3	$635K	Hold	6,464	–	–	0.38%	14
2015 Q2	$757K	Hold	6,464	–	–	0.45%	13
2015 Q1	$634K	Hold	6,464	–	–	0.37%	14
2014 Q4	$609K	Hold	6,464	–	–	0.37%	15
2014 Q3	$688K	Buy	6,464 +34	+0.5%	+$3.33K	0.52%	13
2014 Q2	$533K	Hold	6,430	–	–	0.41%	15
2014 Q1	$456K	Sell	6,430 -34	-0.5%	-$2.67K	0.37%	19
2013 Q4	$609K	Buy	+6,464	New	+$450K	0.37%	15

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

RAFFA WEALTH MANAGEMENT, LLC's GILD Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC reduced its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, selling an estimated $1.19K and leaving 186 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #260.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $757K in Q2 2015. 770 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

RAFFA WEALTH MANAGEMENT, LLC held 186 shares of Gilead Sciences worth $23.5K as of Q2 2026.
RAFFA WEALTH MANAGEMENT, LLC sold 9 Gilead Sciences shares in Q2 2026, an estimated $1.19K.
Gilead Sciences made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #260 holding.
RAFFA WEALTH MANAGEMENT, LLC first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
RAFFA WEALTH MANAGEMENT, LLC's Gilead Sciences position peaked at $757K in Q2 2015.
770 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.